Luye Pharma's market value is the price at which a share of Luye Pharma trades on a public exchange. It measures the collective expectations of Luye Pharma Group investors about its performance. Luye Pharma is trading at 0.34 as of the 8th of January 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.34. With this module, you can estimate the performance of a buy and hold strategy of Luye Pharma Group and determine expected loss or profit from investing in Luye Pharma over a given investment horizon. Check out Luye Pharma Correlation, Luye Pharma Volatility and Luye Pharma Alpha and Beta module to complement your research on Luye Pharma.
Please note, there is a significant difference between Luye Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Luye Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Luye Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Luye Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Luye Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Luye Pharma.
0.00
12/09/2024
No Change 0.00
0.0
In 30 days
01/08/2025
0.00
If you would invest 0.00 in Luye Pharma on December 9, 2024 and sell it all today you would earn a total of 0.00 from holding Luye Pharma Group or generate 0.0% return on investment in Luye Pharma over 30 days. Luye Pharma is related to or competes with Amgen, Bristol Myers, Roche Holding, Novartis, Scilex Holding, Roche Holding, and Novartis. Luye Pharma Group Ltd. develops, produces, markets, and sells pharmaceutical products worldwide More
Luye Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Luye Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Luye Pharma Group upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Luye Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Luye Pharma's standard deviation. In reality, there are many statistical measures that can use Luye Pharma historical prices to predict the future Luye Pharma's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Luye Pharma. Your research has to be compared to or analyzed against Luye Pharma's peers to derive any actionable benefits. When done correctly, Luye Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Luye Pharma Group.
Luye Pharma Group Backtested Returns
At this point, Luye Pharma is extremely dangerous. Luye Pharma Group has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We have found seventeen technical indicators for Luye Pharma, which you can use to evaluate the volatility of the firm. Please verify Luye Pharma's Mean Deviation of 0.2888, standard deviation of 1.19, and Risk Adjusted Performance of 0.1028 to check out if the risk estimate we provide is consistent with the expected return of 0.16%. Luye Pharma has a performance score of 10 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.0696, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Luye Pharma are expected to decrease at a much lower rate. During the bear market, Luye Pharma is likely to outperform the market. Luye Pharma Group right now secures a risk of 1.24%. Please verify Luye Pharma Group standard deviation, as well as the relationship between the maximum drawdown and day median price , to decide if Luye Pharma Group will be following its current price movements.
Auto-correlation
1.00
Perfect predictability
Luye Pharma Group has perfect predictability. Overlapping area represents the amount of predictability between Luye Pharma time series from 9th of December 2024 to 24th of December 2024 and 24th of December 2024 to 8th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Luye Pharma Group price movement. The serial correlation of 1.0 indicates that 100.0% of current Luye Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient
1.0
Spearman Rank Test
1.0
Residual Average
0.0
Price Variance
0.0
Luye Pharma Group lagged returns against current returns
Autocorrelation, which is Luye Pharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Luye Pharma's pink sheet expected returns. We can calculate the autocorrelation of Luye Pharma returns to help us make a trade decision. For example, suppose you find that Luye Pharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Luye Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Luye Pharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Luye Pharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Luye Pharma pink sheet over time.
Current vs Lagged Prices
Timeline
Luye Pharma Lagged Returns
When evaluating Luye Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Luye Pharma pink sheet have on its future price. Luye Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Luye Pharma autocorrelation shows the relationship between Luye Pharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Luye Pharma Group.
Luye Pharma financial ratios help investors to determine whether Luye Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Luye with respect to the benefits of owning Luye Pharma security.